When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Amgen (NASDAQ:AMGN) and collaboration partner Allergan (NYSE:AGN) announce positive results from a second Phase 3 clinical trial, JASMINE, evaluating biosimilar candidate ABP 798 to the branded product, Roche's (OTCQX:RHHBY) Rituxan (rituximab) in patients with CD20-positive B-cell non-Hodgkin lymphoma. The data showed clinical equivalence as well as comparable safety and immunogenicity.
More news on: Amgen Inc., Allergan plc, Roche Holding AG, Healthcare stocks news,